216.02

3.21% -7.16

After Hours: 216.70 0.68 +0.31%

Cardinal Health Inc (CAH)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Cardinal Health Inc stock is traded at $216.02, with a volume of 2.85M. It is down -3.21% in the last 24 hours and down -4.91% over the past month. Cardinal Health is one of three leading pharmaceutical wholesalers in the US, engaged in sourcing and distributing of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. Cardinal, Cencora, and McKesson hold well over 90% of the US pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.

Previous Close:

$223.18

Open:

$222.1

24h Volume:

2.85M

Relative Volume:

1.56

Market Cap:

$50.83B

Revenue:

$244.67B

Net Income/Loss:

$1.68B

P/E Ratio:

31.09

EPS:

6.9487

Net Cash Flow:

$5.51B

1W Performance:

-4.89%

1M Performance:

-4.91%

6M Performance:

+44.44%

1Y Performance:

+69.53%

1-Day Range:

$215.89

$222.38

1-Week Range:

$215.89

$233.60

52-Week Range:

$120.72

$233.60

Cardinal Health Inc Stock (CAH) Company Profile

Name

Cardinal Health Inc

Sector

Healthcare (1108)

Industry

Medical Distribution (12)

Phone

(614) 757-3033

Address

7000 CARDINAL PLACE, DUBLIN, OH

Employee

57,700

Twitter

@cardinalhealth

Next Earnings Date

2024-11-01

Latest SEC Filings

CAH's Discussions on Twitter

Compare CAH vs MCK, COR, HSIC, AHG

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CAH Cardinal Health Inc	216.02	52.52B	244.67B	1.68B	5.51B	6.9487
MCK Mckesson Corporation	931.35	119.88B	397.96B	4.55B	9.64B	34.77
COR Cencora Inc	359.28	71.62B	325.78B	1.64B	3.61B	8.3139
HSIC Henry Schein Inc	80.17	9.24B	13.18B	419.00M	521.00M	3.2704
AHG Akso Health Group Adr	1.35	1.16B	2.22M	-5.63M	-1.68M	-0.24

Cardinal Health Inc Stock (CAH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-09-26	Upgrade	Citigroup	Neutral → Buy
Dec-09-25	Initiated	Barclays	Overweight
Jun-03-25	Upgrade	Wells Fargo	Equal Weight → Overweight
Feb-05-25	Upgrade	Jefferies	Hold → Buy
Jan-08-25	Upgrade	TD Cowen	Hold → Buy
Jan-07-25	Upgrade	Evercore ISI	In-line → Outperform
Jan-06-25	Upgrade	BofA Securities	Neutral → Buy
Dec-13-24	Upgrade	Wells Fargo	Underweight → Equal Weight
Dec-04-24	Resumed	Mizuho	Outperform
Feb-26-24	Initiated	Leerink Partners	Outperform
Feb-09-24	Upgrade	Argus	Hold → Buy
Jan-03-24	Initiated	Barclays	Overweight
Dec-14-23	Initiated	Wells Fargo	Underweight
Jul-10-23	Downgrade	Evercore ISI	Outperform → In-line
Mar-31-23	Initiated	Citigroup	Neutral
Feb-03-23	Upgrade	Robert W. Baird	Neutral → Outperform
Nov-04-22	Upgrade	BofA Securities	Underperform → Neutral
Aug-22-22	Resumed	Morgan Stanley	Overweight
May-26-22	Downgrade	Barclays	Overweight → Equal Weight
May-18-22	Upgrade	Evercore ISI	In-line → Outperform
Apr-12-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Apr-01-22	Resumed	Credit Suisse	Neutral
Aug-06-21	Downgrade	Deutsche Bank	Buy → Hold
Aug-05-21	Downgrade	BofA Securities	Buy → Underperform
May-10-21	Downgrade	Robert W. Baird	Outperform → Neutral
Jan-08-21	Upgrade	Wolfe Research	Underperform → Peer Perform
Nov-02-20	Upgrade	Barclays	Equal Weight → Overweight
Sep-25-20	Upgrade	Deutsche Bank	Hold → Buy
Jul-20-20	Upgrade	Guggenheim	Neutral → Buy
May-15-20	Upgrade	UBS	Neutral → Buy
Apr-23-20	Resumed	Credit Suisse	Neutral
Mar-20-20	Upgrade	BofA/Merrill	Underperform → Buy
Feb-12-20	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Feb-07-20	Upgrade	Robert W. Baird	Neutral → Outperform
Dec-16-19	Downgrade	Guggenheim	Buy → Neutral
Sep-12-19	Initiated	Deutsche Bank	Hold
Aug-27-19	Downgrade	Argus	Buy → Hold
Aug-20-19	Upgrade	Guggenheim	Neutral → Buy
Apr-18-19	Initiated	Guggenheim	Neutral
Jan-17-19	Initiated	UBS	Neutral
Nov-16-18	Downgrade	Leerink Partners	Outperform → Mkt Perform
Apr-24-18	Upgrade	Leerink Partners	Mkt Perform → Outperform
Apr-02-18	Upgrade	Argus	Hold → Buy
Mar-08-18	Initiated	Barclays	Equal Weight
Feb-27-18	Resumed	BofA/Merrill	Underperform
Jan-05-18	Initiated	Evercore ISI	In-line

View All

Cardinal Health Inc Stock (CAH) Latest News

10:56 AM

Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now - TradingView

10:56 AM

10:35 AM

Cardinal Health (CAH) Announces Upcoming Retirement of Chief Acc - GuruFocus

10:35 AM

10:33 AM

Cardinal (CAH) Is Considered a Good Investment by Brokers: Is That True? - Finviz

10:33 AM

07:41 AM

Cardinal Health Announces Planned Chief Accounting Officer Transition - TipRanks

07:41 AM

07:40 AM

Cardinal Health chief accounting officer plans retirement in 2027 - Investing.com India

07:40 AM

06:41 AM

Picton Mahoney Asset Management Trims Stake in Cardinal Health, Inc. $CAH - MarketBeat

06:41 AM

Mar 04, 2026

Q4 Earnings Roundup: Cardinal Health (NYSE:CAH) And The Rest Of The Healthcare Providers & Services Segment - Yahoo Finance

Mar 04, 2026

Skba Capital Management LLC Cuts Holdings in Cardinal Health, Inc. $CAH - MarketBeat

Mar 04, 2026

How Strong Quarterly Results and Valuation Signals Will Impact Cardinal Health (CAH) Investors - simplywall.st

Mar 04, 2026

Mar 03, 2026

Insider Sell: Michelle Greene Sells Shares of Cardinal Health In - GuruFocus

Mar 03, 2026

Cardinal Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Mar 03, 2026

Cardinal Health CIO Sells Company Shares - TradingView

Mar 03, 2026

[Form 4] CARDINAL HEALTH INC Insider Trading Activity - Stock Titan

Mar 03, 2026

Cardinal Health (CAH) Valuation Check After Strong Recent Share Price Returns - Yahoo Finance

Mar 03, 2026